Measurement of Early and Late Repolarization Periods in Addition to QT Interval to Help Predict the Torsadogenic Risk of Donepezil Based on Reverse Translational Animal Research on Its Proarrhythmic Potential.
作者信息
Kambayashi Ryuichi, Goto Ai, Izumi-Nakaseko Hiroko, Matsumoto Akio, Sugiyama Atsushi
机构信息
Department of Pharmacology, Faculty of Medicine, Toho University Tokyo Japan.
Department of Aging Pharmacology, Faculty of Medicine, Toho University Tokyo Japan.
出版信息
Circ Rep. 2021 Aug 6;3(9):555-556. doi: 10.1253/circrep.CR-21-0061. eCollection 2021 Sep 10.
Abstract
摘要
相似文献
1
Measurement of Early and Late Repolarization Periods in Addition to QT Interval to Help Predict the Torsadogenic Risk of Donepezil Based on Reverse Translational Animal Research on Its Proarrhythmic Potential.基于对多奈哌齐致心律失常潜力的反向转化动物研究，除测量QT间期外，还测量早期和晚期复极期，以帮助预测多奈哌齐的致尖端扭转型室速风险。
Circ Rep. 2021 Aug 6;3(9):555-556. doi: 10.1253/circrep.CR-21-0061. eCollection 2021 Sep 10.
2
Measurement of Early and Late Repolarization Periods in Addition to QT Interval to Help Predict the Torsadogenic Risk of Donepezil Based on Reverse Translational Animal Research on Its Proarrhythmic Potential - Reply.基于对多奈哌齐促心律失常潜力的反向转化动物研究，除测量QT间期外，还测量早期和晚期复极期以帮助预测多奈哌齐的致扭转型室性心动过速风险——回复
Circ Rep. 2021 Aug 6;3(9):556-557. doi: 10.1253/circrep.CR-21-0086. eCollection 2021 Sep 10.
3
Nonclinical proarrhythmia models: predicting Torsades de Pointes.非临床致心律失常模型：预测尖端扭转型室速
J Pharmacol Toxicol Methods. 2005 Jul-Aug;52(1):46-59. doi: 10.1016/j.vascn.2005.04.011.
4
Proarrhythmic Effect of Acetylcholine-Esterase Inhibitors Used in the Treatment of Alzheimer's Disease: Benefit of Rivastigmine in an Experimental Whole-Heart Model.乙酰胆碱酯酶抑制剂治疗阿尔茨海默病的致心律失常作用：利伐斯的明在实验性全心模型中的获益。
Cardiovasc Toxicol. 2020 Apr;20(2):168-175. doi: 10.1007/s12012-019-09543-8.
5
[Proarrhythmic (torsadogenic) effects of QT-prolonging non-antiarrhythmic drugs].[延长QT间期的非抗心律失常药物的促心律失常（扭转型室性心动过速）作用]
Orv Hetil. 2005 Mar 6;146(10):451-60.
6
Utility of the JT Peak Interval and the JT Area in Determining the Proarrhythmic Potential of QT-Shortening Agents.JT 峰间期和 JT 面积在确定 QT 缩短剂致心律失常潜力中的应用。
J Cardiovasc Pharmacol Ther. 2019 Mar;24(2):160-171. doi: 10.1177/1074248418791999. Epub 2018 Aug 9.
7
Assessment of efficacy of proarrhythmia biomarkers in isolated rabbit hearts with attenuated repolarization reserve.在复极储备减弱的离体兔心脏中对致心律失常生物标志物的疗效评估。
J Cardiovasc Pharmacol. 2014 Sep;64(3):266-76. doi: 10.1097/FJC.0000000000000116.
8
Thorough QT/QTc not so thorough: removes torsadogenic predictors from the T-wave, incriminates safe drugs, and misses profibrillatory drugs.全面的QT/QTc间期测量并非如此全面：它从T波中去除了致扭转型室速的预测因素，将安全药物认定为有罪，却遗漏了促心律失常药物。
J Cardiovasc Electrophysiol. 2006 Mar;17(3):337-40. doi: 10.1111/j.1540-8167.2006.00347.x.
9
Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.在兔尖端扭转型室速心脏模型中抗精神病药物舍吲哚的电生理特性：尽管QT间期延长，但致尖端扭转型室速潜力较低。
J Pharmacol Exp Ther. 2002 Jan;300(1):64-71. doi: 10.1124/jpet.300.1.64.
10
Safety pharmacology assessment of drug-induced QT-prolongation in dogs with reduced repolarization reserve.对复极储备降低的犬类进行药物诱导的QT间期延长的安全性药理学评估。
J Pharmacol Toxicol Methods. 2006 Sep-Oct;54(2):130-40. doi: 10.1016/j.vascn.2006.03.011. Epub 2006 Apr 25.
本文引用的文献
1
Effect of QT Prolongation in Patients Taking Cholinesterase Inhibitors (Donepezil) for Alzheimer's Disease.服用胆碱酯酶抑制剂（多奈哌齐）治疗阿尔茨海默病患者的QT间期延长效应。
Circ Rep. 2021 Feb 26;3(3):115-121. doi: 10.1253/circrep.CR-20-0115.
2
Cardiohemodynamic and Arrhythmogenic Effects of the Anti-Atrial Fibrillatory Compound Vanoxerine in Halothane-Anesthetized Dogs.抗心房颤动化合物瓦诺昔林对氟烷麻醉犬的心脏血流动力学和致心律失常作用
Cardiovasc Toxicol. 2021 Mar;21(3):206-215. doi: 10.1007/s12012-020-09612-3. Epub 2020 Oct 19.
3
Analysis of electropharmacological and proarrhythmic effects of donepezil using the halothane-anesthetized intact dogs and the conscious chronic atrioventricular block ones.采用氟烷麻醉的完整狗和清醒慢性房室传导阻滞狗分析多奈哌齐的电药理学和致心律失常作用。
Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):581-589. doi: 10.1007/s00210-020-01997-w. Epub 2020 Oct 16.
4
Donepezil-induced QTc prolongation: A case report.多奈哌齐诱发的QTc间期延长：一例报告。
Ment Health Clin. 2019 May 10;9(3):128-132. doi: 10.9740/mhc.2019.05.128. eCollection 2019 May.
5
Donepezil-induced torsades de pointes without QT prolongation.多奈哌齐诱发的尖端扭转型室速，无QT间期延长。
J Cardiol Cases. 2013 Jun 25;8(2):e69-e71. doi: 10.1016/j.jccase.2013.05.004. eCollection 2013 Aug.
6
A case of donepezil-related torsades de pointes.一例与多奈哌齐相关的尖端扭转型室性心动过速。
BMJ Case Rep. 2015 Oct 5;2015:bcr2015211900. doi: 10.1136/bcr-2015-211900.
7
Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil.心电图上鉴别药物诱导的多通道阻滞：多非利特、奎尼丁、雷诺嗪和维拉帕米的随机研究。
Clin Pharmacol Ther. 2014 Nov;96(5):549-58. doi: 10.1038/clpt.2014.155. Epub 2014 Jul 23.
8
Torsades de Pointes with QT prolongation related to donepezil use.多形性室性心动过速伴 QT 延长与多奈哌齐的使用有关。
J Cardiol. 2009 Dec;54(3):507-11. doi: 10.1016/j.jjcc.2009.03.011. Epub 2009 May 7.
9
Donepezil-induced adverse side effects of cardiac rhythm: 2 cases report of atrioventricular block and Torsade de Pointes.多奈哌齐引起的心律不良反应：2例房室传导阻滞和尖端扭转型室速报告
Intern Med. 2009;48(14):1219-23. doi: 10.2169/internalmedicine.48.2181. Epub 2009 Jul 15.
10
Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts.用于预测心脏重构患者药物诱导尖端扭转型室速的敏感且可靠的体内致心律失常动物模型。
Br J Pharmacol. 2008 Aug;154(7):1528-37. doi: 10.1038/bjp.2008.240. Epub 2008 Jun 16.
Zotero 插件